A health worker from Alaska developed a severe allergic reaction after receiving the Pfizer vaccine for coronavirus, the New York Times reported, citing three people who have become aware of the person’s state of health.
The allergic reaction occurred on Tuesday and this person is in stable condition, after being admitted to hospital.
According to the report, it has not been clarified whether the vaccinated person had a history of allergic reactions.
Pfizer has not commented on this information.
The FDA has advised people with allergies to consult their doctors before getting the vaccine to see if they are allergic to any ingredient in the vaccine.
Earlier this month, the British AEO announced that those with a history of anaphylaxis to drugs or food should not get the Pfizer-BioNTech vaccine.
Washington works with Pfizer to address ‘challenges’ in vaccine production
U.S. authorities are working with Pfizer Inc. to help maximize production of the Covid-19 vaccine, after the pharmaceutical company announced that it may face “challenges” in its production, US Secretary of Health Alex Azar said today.
Pfizer did not respond to a request for comment. Earlier this week, however, Albert Burla, the company’s chief executive, told CNBC that he had asked the US government to use the Defense Production Act to remove some critical “supply restrictions”, especially on some components. . However, he did not give further details about the possible shortcomings.
US officials did not specify what the specific “challenges” to production were. However, they said that they are familiar with the materials and equipment required for the production of vaccines, from the experience they have from their cooperation with other pharmaceutical companies.
“We have recently been briefed by them on the various challenges they may face in production and we will ensure that through whatever mechanism is needed, we will provide them with full support to ensure production for the American people,” Azar said.
In the same telephone press conference, Dr Moncef Slawie, an adviser to US Operation Speed Vortex, said the US government was in talks with Pfizer to secure an additional 100 million doses of its vaccine.
Earlier, officials said the United States had already signed contracts to buy 300 million doses from Pfizer / BioNTech and Moderna and a total of 900 million doses from pharmaceutical companies developing vaccines for Covid-19. They added that the Moderna vaccine is likely to receive approval from the authorities on Friday.